Heterocyclic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device
US-2024373662-A1 · Nov 7, 2024 · US
US11359096B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11359096-B2 |
| Application number | US-201916403041-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 3, 2019 |
| Priority date | Aug 2, 2018 |
| Publication date | Jun 14, 2022 |
| Grant date | Jun 14, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed is a fluorescent probe specifically labeling mitochondria, which can exhibit high transmittance by virtue of light emission in the NIR range and in which nonspecific fluorescence absorption in biomolecules can be avoided, making it possible to observe fluorescence images in deep tissue.
Opening claim text (preview).
What is claimed is: 1. A compound represented by Chemical Formula 1 below 2. A fluorescent probe for labeling mitochondria, represented by Chemical Formula 1 below 3. A method of detecting mitochondria using the compound represented by Chemical Formula 1 of claim 1 , comprising: preparing a solution by dissolving the compound represented by Chemical Formula 1 in a solvent; and adding the solution to a sample including cells. 4. The method of claim 3 , further comprising: applying light at a predetermined wavelength to the sample added with the compound represented by Chemical Formula 1; and measuring a fluorescence emitted from the sample. 5. A method of preparing a compound for labeling mitochondria, the method comprising forming a compound represented by Chemical Formula 1 below by reacting a compound represented by Chemical Formula 4 below, acetonitrile and methyl iodide, 6. The method of claim 5 , wherein the compound represented by Chemical Formula 4 is formed by dissolving a compound represented by Chemical Formula 3 below, 2-pyridine carbaldehyde, pyrrolidine and acetic acid in acetonitrile and carrying out a reaction with addition of a molecular sieve, 7. The method of claim 6 , wherein the compound represented by Chemical Formula 3 is formed by reacting a compound represented by Chemical Formula 2 below, hydrazine and Pd/C in ethanol, removing Pd/C through celite, performing purification to give a powder, dissolving the powder in a mixed solution of hydrochloric acid and methanol, carrying out a reaction with addition of a sodium nitrite solution, and carrying out a reaction with addition of a sodium azide solution, 8. The method of claim 7 , wherein the compound represented by Chemical Formula 2 is formed by dissolving 2,4-dimethylpyrrole and 4-nitrobenzaldehyde in dichloromethane, carrying out a reaction with addition of trifluoroacetic acid, carrying out a reaction with addition of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone dissolved in dichloromethane, carrying out a reaction with addition of diisopropylethylamine, and carrying out a reaction with addition of boron trifluoride etherate.
Organoboranes and organoborohydrides · CPC title
one >CH- group, e.g. cyanines, isocyanines, pseudocyanines · CPC title
bridged by heteroatoms, e.g. N, P, Si or B · CPC title
with indicators, stains, dyes, tags, labels, marks · CPC title
containing organic luminescent materials · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.